A Phase 1 Randomized Study of MEDI-551 in Subjects With Relapsing Forms of Multiple Sclerosis
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2016
At a glance
- Drugs Inebilizumab (Primary) ; Interferon beta-1a
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors MedImmune
- 15 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 Apr 2015 Planned End Date changed from 1 Feb 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
- 13 Apr 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Jan 2015 as reported by ClinicalTrials.gov record.